Vaginal immunity in the HSV-2 mouse model.
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted pathogen that infects the genital tract. Efforts to develop vaccines to protect women against this and other sexually transmitted pathogens would be facilitated by a better understanding of the immune mechanisms that protect the female reproductive tract against such infections. Such information would be invaluable in developing vaccine strategies to promote the type and magnitude of immune responses in the genital tract that would effectively protect against infection. This review focuses on recent studies using a progestin-treated adult mouse model to explore mucosal immunity to HSV-2 in the vagina. Evidence indicating a major role for both humoral and T cell immunity is presented.
Parr
Margaret B
MB
Department of Anatomy, Southern Illinois University, Carbondale, Illinois 62901-6523, USA. mparr@siumed.edu
Parr
Earl L
EL
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D006558:Herpes Genitalis / Q000276:immunology* / Q000517:prevention & control; D018258:Herpesvirus 2, Human / Q000276:immunology*; D022283:Herpesvirus Vaccines / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007111:Immunity, Cellular; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000378:metabolism; D007074:Immunoglobulin G / Q000097:blood / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D014621:Vagina / Q000276:immunology*
D022283:Herpesvirus Vaccines; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D007371:Interferon-gamma